Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2005
08/31/2005EP1240168B1 Bicyclic inhibitors of glycogen synthase kinase 3
08/31/2005EP1237875B1 Substituted imidazole neuropeptide y y5 receptor antagonists
08/31/2005EP1230925B1 Use of a trifluridine derivative alone or combined with a thymidine phosphorylase inhibitor for the treatment of hiv
08/31/2005EP1224192B1 Half-sandwich ruthenium (ii) compounds comprising nitrogen containing ligands for treatment of cancer
08/31/2005EP1182200B1 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
08/31/2005EP1169060B1 Sodium channel blocker compositions and the use thereof
08/31/2005EP1169032B1 Ketoprofen microgranules, method for preparing the same and pharmaceutical compositions
08/31/2005EP1163212B1 Amide derivatives
08/31/2005EP1163204B1 Lipoxin compounds and their use
08/31/2005EP1156856B1 Use of fluorinated triazoles for the treatment of neuropathic pain
08/31/2005EP1156047B1 6-substituted-7- heteroquinoxaline carboxylic acid derivatives and addition salts thereof and processes for the preparation of both
08/31/2005EP1150579B1 Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven carbon fatty acid
08/31/2005EP1140809B1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
08/31/2005EP1135140B1 iBANDRONIC ACID FOR THE PROMOTION OF THE OSSEOINTEGRATION OF ENDOPROSTHESES
08/31/2005EP1117424B1 Null igf for the treatment of cancer
08/31/2005EP1117297B1 Synthetic analogs of ecteinascidin-743
08/31/2005EP1095020B1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them
08/31/2005EP1085864B1 Method of hiv and hpv prophylaxis
08/31/2005EP1078064B1 Compounds from moraxella catarrhalis
08/31/2005EP1073634B1 Method for producing enantiomerically pure n-methyl-n- (1s)-1-phenyl- 2-((3s)- 3-hydroxypyrrolidine- 1-yl)ethyl]- 2,2-diphenyl acetamide
08/31/2005EP1070048B1 Calcilytic compounds
08/31/2005EP1069894B1 Spisulosine compounds having antitumour activity
08/31/2005EP1066284B1 Benzo(c)quinolizine derivatives and their use as 5 alpha-reductases inhibitors
08/31/2005EP1058542B1 Method for producing encased spherical granular grains comprising prostane derivatives
08/31/2005EP1054668B1 Use of riluzole in the treatment of retinal ischemia
08/31/2005EP1050525B1 Substances capable of inducing apoptosis
08/31/2005EP1035833B1 Compositions for nasal administration
08/31/2005EP1011676B1 Quinoline-urea derivatives for the treatment of withdrawal syndrome and withdrawal-induced brain damage
08/31/2005EP1003497B1 Il-8 receptor antagonists
08/31/2005EP0996731B1 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses
08/31/2005EP0989973B1 Chalcones having antiproliferative activity
08/31/2005EP0984780B1 Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome and gestational diabetes
08/31/2005EP0973819B1 Non-antigenic branched polymer conjugates
08/31/2005EP0955993B1 Topical composition and method for enhancing lipid barrier synthesis
08/31/2005EP0939653B1 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications
08/31/2005EP0888333B1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
08/31/2005EP0882718B1 Benzimidazole derivatives
08/31/2005EP0869813B1 Use of beta-interferons to treat restenosis
08/31/2005EP0869784B1 Inhibition of fatty acid synthase as a means to reduce adipocyte mass
08/31/2005EP0721335B1 Mycophenolate mofetil high dose oral suspensions
08/31/2005CN1662664A Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
08/31/2005CN1662663A DNA enzyme to inhibit plasminogen activator inhibitor-1
08/31/2005CN1662655A Beta glucan-containing fat and oil compositions and novel microorganism capable of producing beta-glucan
08/31/2005CN1662654A Preparation of microbial oil containing polyunsaturated fatty acids
08/31/2005CN1662642A Pasteurisation process for microbial cells and microbial oil
08/31/2005CN1662586A Hydrous gel and production process and use of the hydrous gel
08/31/2005CN1662549A Glucocorticoid receptor ligands for the treatment of metabolic disorders
08/31/2005CN1662548A Regeneration of endogenous myocardial tissue by induction of neovascularization
08/31/2005CN1662544A Novel tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
08/31/2005CN1662542A Heterocyclic compounds
08/31/2005CN1662541A Furyl compounds
08/31/2005CN1662540A 2-(quinolonyl)-fused heterocycles as androgen receptor modulators
08/31/2005CN1662539A [1, 4]diazocino [7, 8, 1-hi]indole derivatives as antipsychotic and antiobesity agents
08/31/2005CN1662538A Arylalkyl indoles having sertonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
08/31/2005CN1662537A Pyrazolo (1, 5-a) pyrimidine derivative and nad(p)h oxidase inhibitor containing the same
08/31/2005CN1662534A 1, 2, 3, 4, 7, 8-hexahydro-6h-[1, 4]diazepino[6, 7, 1-1j]quinoline derivatives as antipsychotic and antiobesity agents
08/31/2005CN1662533A [1, 4]diazepino[6, 7, 1-ij]quinoline derivatives as anti psychotic and antiobesity agents
08/31/2005CN1662531A Hetero-bicyclic compounds
08/31/2005CN1662530A Azabicyclo-octane and nonane derivatives with DPP-IV inhibiting activity
08/31/2005CN1662529A Thiazole derivatives as phosphodiesterase IV inhibitors
08/31/2005CN1662528A Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or cns disorders
08/31/2005CN1662526A Hydroxy pyranone derivative and preparation method thereof
08/31/2005CN1662524A Indole derivatives useful as histamine h3 antagonists
08/31/2005CN1662523A Novel process
08/31/2005CN1662522A Novel compounds, their use and preparation
08/31/2005CN1662521A Compounds useful for the treatment of obesity, type ii diabetes and cns disorders
08/31/2005CN1662519A Heterocyclic compounds as glycine transport inhibitors
08/31/2005CN1662516A N, N-disubstituted diazocycloalkanes
08/31/2005CN1662515A Amorphous form of(-)-}2-}4-}(4-chlorophenyl)-phenyl methyl}-1-piperazinyl] ethoxy] acetic acid dihydrochloride (levocetririzine dihydrochloride)
08/31/2005CN1662514A Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
08/31/2005CN1662513A 2-thioxothiazole derivative, method for preparing the same, and pharmaceutical composition containing the same
08/31/2005CN1662511A Pharmaceutical salts of reboxetine
08/31/2005CN1662509A Pyrrolo-triazine aniline compounds useful as kinase inhibitors
08/31/2005CN1662508A Compounds, compositions and methods
08/31/2005CN1662506A Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
08/31/2005CN1662505A Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same
08/31/2005CN1662504A 2, 5-disubstituted 3-mercaptopentanoic acid
08/31/2005CN1662502A Cyanoguanidine produgs
08/31/2005CN1662501A Cyanoguanidine prodrugs
08/31/2005CN1662500A Novel azasugar derivative and drug containing the same as the active ingredient
08/31/2005CN1662498A Novel tetrahydropyridine derivatives as renin inhibitors
08/31/2005CN1662497A Derivative of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics
08/31/2005CN1662496A Cannabinoid receptor agonists
08/31/2005CN1662495A Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
08/31/2005CN1662494A Cationically substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
08/31/2005CN1662493A Ring -substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
08/31/2005CN1662490A Nitrooxyderivatives of cyclooxygenase-2 inhibitors
08/31/2005CN1662487A Amide linker peroxisome proliferator activated receptor modulators
08/31/2005CN1662486A Process for chlorinating tertiary alcohols
08/31/2005CN1662280A Method and apparatus for ultrasound treatment of connective tissue
08/31/2005CN1662271A Drug delivery assembly
08/31/2005CN1662259A Process for producing block copolymer/drug composite
08/31/2005CN1662258A Compositions comprising dietary fat complexer and methods for their use
08/31/2005CN1662257A Combination of PDE5 inhibitors with angiotensin II receptor antagonists
08/31/2005CN1662256A Combination of angiotensin II receptor blocker and beta-blocker for secondary prevention of myocardial infarction
08/31/2005CN1662251A Adjuvant enhanced immunotherapy
08/31/2005CN1662248A Compositions against inflammatory processes
08/31/2005CN1662247A Medical composition for prevention and/or treatment of constipation and symptom caused by constipation
08/31/2005CN1662246A Combination therapy wherein a serotonin reuptake inhibitor is used
08/31/2005CN1662245A (20s) 1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses
1 ... 4561 4562 4563 4564 4565 4566 4567 4568 4569 4570 4571 4572 4573 4574 4575 4576 4577 4578 4579 4580 4581 ... 7860